The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanismMary Ann Anderson, Andrew W. Roberts, Jing Deng et al.|Blood|2016Cited by 329
The regulatory mechanisms of cerium oxide nanoparticles in oxidative stress and emerging applications in refractory wound careLijun Yi, Yu Tu, Cheng Yang et al.|Frontiers in Pharmacology|2024Cited by 51